Edmonds Duncan Registered Investment Advisors, LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 145 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
Edmonds Duncan Registered Investment Advisors, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$225,742
-9.7%
17,7470.0%0.06%
-16.0%
Q2 2023$249,878
-8.9%
17,7470.0%0.08%
-11.8%
Q1 2023$274,191
-5.7%
17,7470.0%0.08%
-10.5%
Q4 2022$290,873
-11.3%
17,7470.0%0.10%
-18.1%
Q3 2022$328,000
+40.8%
17,7470.0%0.12%
+45.0%
Q2 2022$233,000
+41.2%
17,7470.0%0.08%
+66.7%
Q1 2022$165,000
+9.3%
17,7470.0%0.05%
+20.0%
Q4 2021$151,000
-75.0%
17,7470.0%0.04%
-78.1%
Q3 2021$603,000
-7.2%
17,7470.0%0.18%
-9.4%
Q2 2021$650,000
-18.3%
17,7470.0%0.20%
-23.5%
Q1 2021$796,000
-1.2%
17,7470.0%0.26%
-1.9%
Q4 2020$806,000
-55.7%
17,747
-50.0%
0.27%
-29.0%
Q3 2020$1,820,000
-14.2%
35,4940.0%0.38%
-17.6%
Q2 2020$2,120,000
+45.0%
35,4940.0%0.46%
+23.7%
Q1 2020$1,462,000
+32.3%
35,494
+100.0%
0.37%
-17.0%
Q4 2019$1,105,000
-8.2%
17,747
-50.0%
0.45%
+77.1%
Q3 2019$1,204,000
+41.3%
35,4940.0%0.25%
+43.8%
Q2 2019$852,000
+106.8%
35,494
+100.0%
0.18%
+2.9%
Q1 2019$412,000
-44.8%
17,747
-50.0%
0.17%
-1.7%
Q4 2018$746,000
+8.6%
35,494
+100.0%
0.17%
-38.1%
Q3 2018$687,000
-1.6%
17,7470.0%0.28%
-7.6%
Q2 2018$698,00017,7470.30%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$72,236,00020.73%
SV Health Investors, LLC 449,951$26,871,00018.64%
Redmile Group, LLC 4,978,941$297,342,0005.49%
Sunesis Advisors, LLC 96,299$5,751,0005.29%
Eversept Partners, LP 418,652$25,001,8973.43%
Opaleye Management Inc. 222,000$13,081,0002.64%
Avoro Capital Advisors LLC 1,860,000$111,079,0002.20%
SPHERA FUNDS MANAGEMENT LTD. 282,965$16,899,0001.59%
SECTORAL ASSET MANAGEMENT INC 224,359$13,399,0001.23%
Artal Group S.A. 650,000$38,818,0001.09%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders